全球胰岛素输注装置市场规模、份额、趋势和成长分析报告（2026-2034年）

预计胰岛素输注设备市场将从 2025 年的 194.3 亿美元成长到 2034 年的 400.2 亿美元，2026 年至 2034 年的复合年增长率为 8.36%。

由于全球糖尿病患者人数不断增加，以及人们对有效血糖管理的意识提升，全球胰岛素输注设备市场正经历稳定成长。智慧胰岛素笔、穿戴式胰岛素帮浦和连网设备等技术创新提高了治疗的便利性和患者依从性。人口老化和久坐的生活方式也加剧了对胰岛素的需求。医疗机构推广早期诊断和持续监测，也推动了已开发国家和新兴国家对先进胰岛素输注系统的应用。

关键成长要素包括微创设备的普及、医疗费用支出的成长以及多个国家有利的报销政策。持续的产品创新，例如蓝牙胰岛素笔和整合式血糖监测系统，正在改变糖尿病管理方式。製药公司正与设备製造商合作，以提高给药的准确性和安全性。此外，发展中地区医疗基础设施的不断完善也为胰岛素输注技术製造商开闢了新的收入来源。

展望未来，数位医疗的融合以及个人化治疗方案的进步预计将对市场产生正面影响。人工智慧（AI）和数据分析技术有望提升剂量优化和患者追踪的效率。远端医疗服务的扩展也加速了远距糖尿病管理的发展。随着患者对便利性和便携性的日益重视，製造商正致力于开发紧凑、自动化且用户友好的系统，预计将推动全球胰岛素输注设备市场的持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球胰岛素输注装置市场：依产品划分

• 市场分析、洞察与预测
• 胰岛素笔
• 胰岛素帮浦
• 胰岛素笔针头
• 胰岛素注射器
• 其他产品

第五章 全球胰岛素输注装置市场：依最终用途划分

• 市场分析、洞察与预测
• 医院和诊所
• 居家照护
• 其他最终用户

第六章 全球胰岛素输注设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Novo Nordisk A/S
  • Sanofi
  • Eli Lilly And Company
  • Ypsomed AG
  • Medtronic
  • Insulet Corporation
  • B. Braun SE
  • Owen Mumford Ltd
  • Tandem Diabetes Care Inc
  • BD（Becton Dickinson Company）

The Insulin Delivery Devices Market size is expected to reach USD 40.02 Billion in 2034 from USD 19.43 Billion (2025) growing at a CAGR of 8.36% during 2026-2034.

The Global Insulin Delivery Devices Market is witnessing steady growth due to the rising prevalence of diabetes worldwide and increasing awareness about effective glucose management. Technological advancements such as smart insulin pens, wearable insulin pumps, and connected devices are improving convenience and patient compliance. Growing geriatric populations and sedentary lifestyles are further contributing to higher insulin demand. Healthcare providers are also promoting early diagnosis and continuous monitoring, which is supporting the adoption of advanced insulin delivery systems across both developed and emerging economies.

Key growth drivers include the shift toward minimally invasive devices, rising healthcare expenditure, and favorable reimbursement policies in several countries. Continuous product innovation, including Bluetooth-enabled pens and integrated glucose monitoring systems, is transforming diabetes management. Pharmaceutical companies are collaborating with device manufacturers to enhance delivery precision and safety. Additionally, expanding healthcare infrastructure in developing regions is opening new revenue streams for manufacturers of insulin delivery technologies.

Looking ahead, the market is expected to benefit from increasing digital health integration and personalized treatment approaches. Artificial intelligence and data analytics will likely enhance dose optimization and patient tracking. Expanding telemedicine services are also encouraging remote diabetes management. With growing patient preference for convenient and portable devices, manufacturers are expected to focus on compact, automated, and user-friendly systems, ensuring sustained long-term growth in the global insulin delivery devices market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Insulin Pens
• Insulin Pumps
• Insulin Pen Needles
• Insulin Syringes
• Other Products

By End Use

• Hospitals & Clinics
• Homecare
• Other End Users

COMPANIES PROFILED

• Novo Nordisk AS, Sanofi, Eli Lilly and Company, Ypsomed AG, Medtronic, Insulet Corporation, B Braun SE, Owen Mumford Ltd, Tandem Diabetes Care Inc, BD Becton Dickinson Company
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INSULIN DELIVERY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Insulin Pens Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Insulin Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Insulin Pen Needles Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Insulin Syringes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INSULIN DELIVERY DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INSULIN DELIVERY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INSULIN DELIVERY DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Novo Nordisk A/S
  • 8.2.2 Sanofi
  • 8.2.3 Eli Lilly And Company
  • 8.2.4 Ypsomed AG
  • 8.2.5 Medtronic
  • 8.2.6 Insulet Corporation
  • 8.2.7 B. Braun SE
  • 8.2.8 Owen Mumford Ltd
  • 8.2.9 Tandem Diabetes Care Inc
  • 8.2.10 BD (Becton Dickinson Company)